Columbia University researchers and clinicians are invited to join these regular virtual symposia on COVID-19.
Columbia University researchers and clinicians are invited to join these regular virtual symposia on COVID-19. Researchers and clinicians at all career stages are welcome to educate themselves about Columbia’s efforts against this unprecedented threat to our society.
Please register here with your Columbia UNI.
**Please note: due to intellectual property concerns including the showing of unpublished data, only Columbia affiliates may attend the live symposium. Videos and written summaries of select talks are available on the COVID-19 Virtual Symposia Archive.
Please contact [email protected] with any questions or comments.
Symposium Agenda
8:30 am: Andrea Califano, PhD, Stephen Goff, PhD, Eric Greene, PhD, Andy Marks, MD, Introductory Remarks
8:35 am: Francisca Chou, MD Candidate Class of 2022, Vagelos College of Physicians and Surgeons, Columbia University, "Factors Related to Distress Experienced by Physicians During Their First COVID-19 Triage Decision"
8:55 am: Robin J. Shattock, PhD, Faculty of Medicine, Department of Infectious Disease, Chair in Mucosal Infection and Immunity, Imperial College London, "Development of an saRNA vaccine against COVID-19"
9:25 am: Xiaoli Xiong, PhD, Postdoctoral Research Scientist, Laboratory of Dr. John Briggs, MRC Laboratory of Molecular Biology (LMB), Cambridge, United Kingdom, "Engineering a closed thermostable SARS-CoV-2 Spike Protein"
9:55 am: BREAK
10:05 am: Cristos Kyratsous, PhD, Vice President of Research, Infectious Diseases and Viral Vector Technologies, Regeneron Pharmaceuticals, "Selection, characterization and clinical testing of a fully-human antibody cocktail against SARS-CoV-2 that safeguards against mutational escape"
10:35 am: Danielle Swaney, PhD, Assistant Professor, Cellular Molecular Pharmacology, University of California, San Francisco, "The Global Phosphorylation Landscape of SARS-CoV-2 Infection"
11:05 am: Benjamin Terrier, PhD, Professeur des Universités-Praticien Hospitalier, Université de Paris, Service de Médecine Interne, Hôpital Cochin, "Impaired type 1 interferon activity and exacerbated inflammatory responses in severe Covid-19"
11:35 am: Amy S. Gladfelter, PhD, Associate Professor of Biology, HHMI Faculty Scholar, University of North Carolina at Chapel Hill, "Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate"
Symposium Organizers:
Andrea Califano, PhD, Departments of Chemical and Systems Biology
Stephen Goff, PhD, Departments of Microbiology & Immunology and Biochemistry & Molecular Biophysics
Eric Greene, PhD, Department of Biochemistry & Molecular Biophysics
Andrew Marks, MD, Departments of Physiology & Cellular Biophysics and Molecular Physiology (in Medicine)
The organizers would like to thank volunteers from Columbia Researchers Against COVID-19 for their help in symposium logistics, the Office of the Executive Vice President for Research for web support and the Mailman School of Public Health for webinar support.
About the Symposium Series
Sharing the latest in COVID-19 research at Columbia
Columbia University researchers and clinicians are invited to join these regular virtual symposia on COVID-19. Researchers and clinicians at all career stages are welcome to educate themselves about Columbia’s efforts against this unprecedented threat to our society.
Symposia are held bi-weekly on Wednesdays unless otherwise noted.
Due to intellectual property concerns including the showing of unpublished data, only Columbia affiliates may attend the live symposium. Select videos from the most recent symposium, and summaries of all previous symposia, are available below. Videos of previous symposia are available to watch on YouTube.
Please contact [email protected] with any questions or comments.